Embion Technologies
Embion specializes in the efficient extraction of naturally-derived prebiotics for microbiome nutrition.
Total raised
€4.5M
€4,540,462
Funding rounds
2
Investors
2
distinct backers
Active since
2020-10
latest 2021-12
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood36
base rate 44% for Series A
- ▼ Overdue vs cohort gap
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood13
base rate 12% (2+ rounds)
- ▲ 10y since founding
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-12-08 | Series A | €4.3M | ASAHI Group Holdings | View deal → |
| 2020-10-21 | Grant | €233k | ALCEA Foundation | View deal → |
Investors
2Related news
- Embion closes ASAHI led CHF 4.5M Series A Roundstartupticker.ch · 2021-12
- startupticker.ch
Similar companies
same sector or country- Roivant Sciences€1.2BSwitzerland · Healthtech
- Climeworks€920MSwitzerland · Cleantech
- Energy Vault€896MSwitzerland · Energy
- ABB E-mobility€703MSwitzerland · Energy
- Infarm€697MGermany · Agritech
- ManoMano€610MFrance · Agritech